Zobrazeno 1 - 10
of 278
pro vyhledávání: '"Del Tredici AL"'
Publikováno v:
Pharmacogenomics and Personalized Medicine, Vol Volume 13, Pp 405-414 (2020)
Guang-dan Zhu,1 Eric Dawson,1 Angela Huskey,1 Ronald J Gordon,2 Andria L Del Tredici1 1Millennium Health, LLC, San Diego, CA, USA; 2Department of Anesthesiology, University of California, UC San Diego School of Medicine, La Jolla, CA, USACorresponden
Externí odkaz:
https://doaj.org/article/a8fdaba9bacd4d4686f6718337125ab1
Autor:
Zhu GD; Millennium Health, LLC, San Diego, CA, USA. Dan.Zhu@millenniumhealth.com., Whitley P; Millennium Health, LLC, San Diego, CA, USA., LaRue L; Millennium Health, LLC, San Diego, CA, USA., Adkins B; Millennium Health, LLC, San Diego, CA, USA., Dawson E; Millennium Health, LLC, San Diego, CA, USA., Huskey A; Millennium Health, LLC, San Diego, CA, USA., Capparelli EV; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.; Department of Pediatrics, School of Medicine, University of California San Diego, La Jolla, CA, USA., Del Tredici AL; Millennium Health, LLC, San Diego, CA, USA.
Publikováno v:
The pharmacogenomics journal [Pharmacogenomics J] 2022 Feb; Vol. 22 (1), pp. 25-32. Date of Electronic Publication: 2021 Sep 03.
Autor:
Pratt VM; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana. Electronic address: vpratt@iu.edu., Cavallari LH; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida., Del Tredici AL; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Millennium Health, LLC, San Diego, California., Gaedigk A; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, and School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri., Hachad H; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; private precision medicine consultancy, Seattle, Washington., Ji Y; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Pathology and ARUP Laboratories, University of Utah School of Medicine, Salt Lake City, Utah., Kalman LV; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Division of Laboratory Systems, Centers for Disease Control and Prevention, Atlanta, Georgia., Ly RC; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana., Moyer AM; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Scott SA; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Pathology, Stanford University, Stanford, California; Clinical Genomics Program, Stanford Health Care, Palo Alto, California., van Schaik RHN; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Clinical Chemistry/IFCC Expert center Pharmacogenetics, Erasmus MC University Medical Center, Rotterdam, the Netherlands; European Society of Pharmacogenomics and Personalized Therapy., Whirl-Carrillo M; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Biomedical Data Science, Stanford University, Stanford, California., Weck KE; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Pathology and Laboratory Medicine and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2021 Sep; Vol. 23 (9), pp. 1047-1064. Date of Electronic Publication: 2021 Jun 10.
Autor:
Sangkuhl K; Department of Biomedical Data Science, School of Medicine, Stanford University, Stanford, California, USA., Claudio-Campos K; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida, USA., Cavallari LH; Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida, USA., Agundez JAG; University Institute of Molecular Pathology Biomarkers, University of Extremadura, Asthma, Adverse Drug Reactions and Allergy (ARADyAL) Institute de Salud Carlos III, Cáceres, Spain., Whirl-Carrillo M; Department of Biomedical Data Science, School of Medicine, Stanford University, Stanford, California, USA., Duconge J; School of Pharmacy, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, USA., Del Tredici AL; Acadia Pharmaceuticals Inc., San Diego, California, USA., Wadelius M; Department of Medical Sciences, Clinical Pharmacology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Rodrigues Botton M; Cells, Tissues and Genes Laboratory, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil., Woodahl EL; Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, Montana, USA., Scott SA; Department of Pathology, Stanford University, Stanford, California, USA.; Stanford Health Care Clinical Genomics Laboratory, Palo Alto, California, USA., Klein TE; Department of Biomedical Data Science, School of Medicine, Stanford University, Stanford, California, USA., Pratt VM; Indiana University School of Medicine, Indianapolis, Indiana, USA., Daly AK; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Gaedigk A; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA.; School of Medicine, University of Missouri - Kansas City, Kansas City, Missouri, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Sep; Vol. 110 (3), pp. 662-676. Date of Electronic Publication: 2021 Jul 12.
Autor:
Botton MR; Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil., Whirl-Carrillo M; Department of Biomedical Data Science, Stanford University, Stanford, California, USA., Del Tredici AL; Millennium Health LLC, San Diego, California, USA., Sangkuhl K; Department of Biomedical Data Science, Stanford University, Stanford, California, USA., Cavallari LH; University of Florida, Gainsville, Florida, USA., Agúndez JAG; UNEx, ARADyAL, Instituto de Salud Carlos III, University Institute of Molecular Pathology Biomarkers, Cáceres, Spain., Duconge J; School of Pharmacy, University of Puerto Rico, San Juan, Puerto Rico., Lee MTM; Genomic Medicine Institute, Geisinger, Danville, Pennsylvania, USA., Woodahl EL; Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, Montana, USA., Claudio-Campos K; University of Florida, Gainsville, Florida, USA., Daly AK; Newcastle University, Newcastle upon Tyne, UK., Klein TE; Department of Biomedical Data Science, Stanford University, Stanford, California, USA., Pratt VM; Indiana University School of Medicine, Indianapolis, Indiana, USA., Scott SA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Sema4, Stamford, Connecticut, USA., Gaedigk A; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy, Kansas City, Missouri, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Feb; Vol. 109 (2), pp. 352-366. Date of Electronic Publication: 2020 Jul 22.
Autor:
Pratt VM; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana. Electronic address: vpratt@iu.edu., Cavallari LH; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida., Del Tredici AL; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Millennium Health, LLC, San Diego, California., Hachad H; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Translational Software, Bellevue, Washington., Ji Y; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Pathology and ARUP Laboratories, University of Utah School of Medicine, Salt Lake City, Utah., Kalman LV; Division of Laboratory Systems, Centers for Disease Control and Prevention, Atlanta, Georgia., Ly RC; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana., Moyer AM; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Scott SA; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Sema4, a Mount Sinai venture, Stamford, Connecticut., Whirl-Carrillo M; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Biomedical Data Science, Stanford University, Stanford, California., Weck KE; The Pharmacogenomics Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Departments of Pathology and Laboratory Medicine and Genetics, University of North Carolina, Chapel Hill, North Carolina.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2020 Jul; Vol. 22 (7), pp. 847-859. Date of Electronic Publication: 2020 May 04.
Autor:
Bao S; Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, No. 95 Yongan Road, Xicheng District, Beijing, 100050, China.; Department of Pharmacy, Beijing Anding Hospital, Capital Medical University, No. 5 Ankang Hutong, Xicheng District, Beijing, 100088, China., Yang S; Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, No. 95 Yongan Road, Xicheng District, Beijing, 100050, China., Hua Z; Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, No. 95 Yongan Road, Xicheng District, Beijing, 100050, China., Li J; Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, No. 95 Yongan Road, Xicheng District, Beijing, 100050, China., Zang Y; Department of Pharmacy, Beijing Anding Hospital, Capital Medical University, No. 5 Ankang Hutong, Xicheng District, Beijing, 100088, China., Li X; Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, No. 95 Yongan Road, Xicheng District, Beijing, 100050, China. lxg198320022003@163.com.
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Dec; Vol. 397 (12), pp. 9811-9821. Date of Electronic Publication: 2024 Jun 25.
Publikováno v:
Pharmacogenetics & Genomics; Jun2024, Vol. 34 Issue 4, p130-134, 5p
Autor:
Hernandez, Sophia1 (AUTHOR), Hindorff, Lucia A.1 (AUTHOR), Morales, Joannella1 (AUTHOR), Ramos, Erin M.1 (AUTHOR), Manolio, Teri A.1 (AUTHOR) manolio@nih.gov
Publikováno v:
CTS: Clinical & Translational Science. Sep2024, Vol. 17 Issue 9, p1-11. 11p.
Autor:
Golomb, Beatrice A.1 (AUTHOR) bgolomb@ucsd.edu, Kelley, Richard I.2 (AUTHOR), Han, Jun Hee1 (AUTHOR), Miller, Bruce1 (AUTHOR), Bui, Leeann1,3 (AUTHOR)
Publikováno v:
BMC Research Notes. 8/21/2024, Vol. 17 Issue 1, p1-4. 4p.